RETRACTED: Downregulation of long non-coding RNA GACAT1 suppresses proliferation and induces apoptosis of NSCLC cells by sponging microRNA-422a (Retracted Article)

被引:11
作者
Zhong, Youqing [1 ]
Lin, Hui [2 ]
Li, Qi [1 ]
Liu, Chang [1 ]
Zhong, Lei [3 ]
机构
[1] Hainan Med Univ, Dept Resp Med, Affiliated Hosp 1, Haikou 571100, Hainan, Peoples R China
[2] Hainan Gen Hosp, Dept Anesthesia, Haikou 570311, Hainan, Peoples R China
[3] Ganzhou Peoples Hosp Jiangxi Prov, Clin Lab, 18 Meiguan Rd, Ganzhou 341000, Jiangxi, Peoples R China
关键词
GACAT1; microRNA-422a; NSCLC; apoptosis; cell cycle arrest; TUMOR-SUPPRESSOR; GASTRIC-CANCER; EMERGING ROLE; MIR-422A; CERNA; CONSTRUCTION; PROGRESSION; MIGRATION; NETWORK; BIOLOGY;
D O I
10.3892/ijmm.2020.4826
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Increasing evidence has demonstrated the important roles of long non-coding (lnc) RNA in non-small cell lung cancer (NSCLC). lncRNA gastric cancer-associated transcript 1 (GACAT1) has been reported to play an oncogenic role in different types of cancer; however, the function of GACAT1 in NSCLC remains unclear. The present study found that GACAT1 was overexpressed in NSCLC tissues and was associated with poor outcomes in patients with NSCLC. Functional experiments revealed that GACAT1 downregulation inhibited proliferation, induced apoptosis and cell cycle arrest of 2 NSCLC cell lines. GACAT1 was found to target microRNA(miR)-422a mechanically and negatively regulated miR-422a expression. Reduced expression of miR-422a in NSCLC tissues was inversely correlated with that of GACAT1. Furthermore, YY1 transcription factor (YY1) was identified as a downstream miR-422a target. Reduced expression of GACAT1 inactivated YY1 by sponging miR-422a in NSCLC cells. YY1 reintroduction reversed the reduced proliferation of NSCLC cells via GACAT1 knockdown. Taken together, these results revealed the novel role of the GACAT1/miR-422a pathway in the progression of NSCLC cell lines, providing a possible therapeutic strategy for NSCLC treatment.
引用
收藏
页码:659 / 667
页数:9
相关论文
共 48 条
[1]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[2]   Long Noncoding RNAs: Cellular Address Codes in Development and Disease [J].
Batista, Pedro J. ;
Chang, Howard Y. .
CELL, 2013, 152 (06) :1298-1307
[3]   Diagnostic efficacy of long non-coding RNA in lung cancer: a systematic review and meta-analysis [J].
Dai, Shui-Ping ;
Jin, Jing ;
Li, Wei-Min .
POSTGRADUATE MEDICAL JOURNAL, 2018, 94 (1116) :578-587
[4]  
Do Hyunhee, 2018, Genomics & Informatics, V16, pe18
[5]   Regulation of mRNA Translation and Stability by microRNAs [J].
Fabian, Marc Robert ;
Sonenberg, Nahum ;
Filipowicz, Witold .
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 79, 2010, 79 :351-379
[6]   Rethinking the Optimal Duration of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer Throughout the COVID-19 Pandemic [J].
Friedlaender, Alex ;
Kim, Chul ;
Addeo, Alfredo .
FRONTIERS IN ONCOLOGY, 2020, 10
[7]   Non-coding RNA profile in lung cancer [J].
Ghafouri-Fard, Soudeh ;
Shoorei, Hamed ;
Branicki, Wojciech ;
Taheri, Mohammad .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2020, 114
[8]   YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress [J].
Grönroos, E ;
Terentiev, AA ;
Punga, T ;
Ericsson, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (33) :12165-12170
[9]   LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC) [J].
He, Rong ;
Zhang, Fei Hu ;
Shen, Ning .
BIOMEDICINE & PHARMACOTHERAPY, 2017, 95 :331-338
[10]   MiR-422a regulates cellular metabolism and malignancy by targeting pyruvate dehydrogenase kinase 2 in gastric cancer [J].
He, Zhongyuan ;
Li, Zheng ;
Zhang, Xuan ;
Yin, Kai ;
Wang, Weizhi ;
Xu, Zhipeng ;
Li, Bowen ;
Zhang, Lei ;
Xu, Jianghao ;
Sun, Guangli ;
Wang, Lu ;
Li, Qing ;
Huang, Xiaoxu ;
Zhang, Lu ;
Zhang, Diancai ;
Xu, Hao ;
Xu, Zekuan .
CELL DEATH & DISEASE, 2018, 9